tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ACET Stock Latest News

Adicet Bio Advances with Phase 1 Trial of ADI-270
Company AnnouncementsAdicet Bio Advances with Phase 1 Trial of ADI-270
30d ago
8K
ACET
Adicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCC
PremiumThe Fly
Adicet Bio says 1st patient dosed in Phase1 trial of ADI-270 to treat ccRCC
30d ago
ACET
Adicet Bio appoints Julie Maltzman, M.D. as Chief Medical Officer
PremiumThe Fly
Adicet Bio appoints Julie Maltzman, M.D. as Chief Medical Officer
1M ago
ACET
Adicet Bio Clears Debts with Banc of California
PremiumCompany Announcements
Adicet Bio Clears Debts with Banc of California
2M ago
8K
ACET
Adicet Bio Reports Q3 2024 Results and Clinical Progress
PremiumCompany Announcements
Adicet Bio Reports Q3 2024 Results and Clinical Progress
2M ago
ACET
Adicet Bio Advances Cancer and Autoimmune Trials
PremiumCompany AnnouncementsAdicet Bio Advances Cancer and Autoimmune Trials
2M ago
8K
ACET
Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC
Premium
The Fly
Adicet Bio opens enrollment for ADI-270 phase 1 clinical trial in ccRCC
2M ago
ACET
Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases
Premium
The Fly
Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases
2M ago
ACET
Adicet Bio reports Q3 EPS (34c), consensus (34c)
PremiumThe Fly
Adicet Bio reports Q3 EPS (34c), consensus (34c)
2M ago
ACET
Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
PremiumCompany Announcements
Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
3M ago
8K
ACET
Adicet Bio announces FDA clearance of ADI-001 IND amendment
PremiumThe Fly
Adicet Bio announces FDA clearance of ADI-001 IND amendment
3M ago
ACET
Adicet Bio assumed at Buy from Neutral at Guggenheim
PremiumThe Fly
Adicet Bio assumed at Buy from Neutral at Guggenheim
4M ago
ACET
Adicet Bio Launches Phase 1 Trial of ADI-001, Eyes Expansion
PremiumCompany AnnouncementsAdicet Bio Launches Phase 1 Trial of ADI-001, Eyes Expansion
4M ago
8K
ACET
Adicet Bio opens enrollment for ADI-001
Premium
The Fly
Adicet Bio opens enrollment for ADI-001
4M ago
ACET
Adicet Bio’s GLEAN Trial Shows Promise in Autoimmune Therapy
Premium
Company Announcements
Adicet Bio’s GLEAN Trial Shows Promise in Autoimmune Therapy
4M ago
8K
ACET
Adicet Bio announces clinical biomarker data from GLEAN trial
PremiumThe Fly
Adicet Bio announces clinical biomarker data from GLEAN trial
4M ago
ACET
Adicet Bio price target lowered to $8 from $19 at Canaccord
PremiumThe Fly
Adicet Bio price target lowered to $8 from $19 at Canaccord
4M ago
ACET
Adicet Bio downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Adicet Bio downgraded to Neutral from Buy at H.C. Wainwright
4M ago
ACET
Adicet Bio discontinues Phase 1 ADI-001 study in strategic prioritization
PremiumThe Fly
Adicet Bio discontinues Phase 1 ADI-001 study in strategic prioritization
4M ago
ACET
Adicet Bio price target lowered to $4 from $6 at JonesResearch
PremiumThe FlyAdicet Bio price target lowered to $4 from $6 at JonesResearch
4M ago
ACET
Adicet Bio Boardroom Changes as Leadership Transitions
Premium
Company Announcements
Adicet Bio Boardroom Changes as Leadership Transitions
5M ago
8K
ACET
Adicet Bio reports Q2 EPS (33c), consensus (36c)
Premium
The Fly
Adicet Bio reports Q2 EPS (33c), consensus (36c)
5M ago
ACET

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >